Actions of N-arachidonyl-glycine in a rat neuropathic pain model

This publication has 28 references indexed in Scilit:

• Potential anti-inflammatory actions of the elmiric (lipoamino) acids
  Bioorganic & Medicinal Chemistry, 2007
• CB2 receptor‐mediated antihyperalgesia: possible direct involvement of neural mechanisms
  European Journal of Neuroscience, 2006
• Laminar distribution of GABAA- and glycine-receptor mediated tonic inhibition in the dorsal horn of the rat lumbar spinal cord: effects of picrotoxin and strychnine on expression of Fos-like immunoreactivity
  Pain, 2004
• 3-[2-Cyano-3-(trifluoromethyl)phenoxy]phenyl-4,4,4-trifluoro-1-butanesulfonate (BAY 59-3074): A Novel Cannabinoid CB1/CB2 Receptor Partial Agonist with Antihyperalgesic and Antiallodynic Effects
  The Journal of Pharmacology and Experimental Therapeutics, 2004
• A structure–activity relationship study on N-arachidonoyl-amino acids as possible endogenous inhibitors of fatty acid amide hydrolase
  Biochemical and Biophysical Research Communications, 2004
• Regulation of anandamide tissue levels by N-arachidonylglycine
  Biochemical Pharmacology, 2002
• The synthetic cannabinoid WIN55,212‐2 attenuates hyperalgesia and allodynia in a rat model of neuropathic pain
  British Journal of Pharmacology, 2001
• The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain
  Published by Wolters Kluwer Health ,2001
• The Cannabinoid Acids
  Pharmacology & Therapeutics, 1999
• Quantitative assessment of tactile allodynia in the rat paw
  Journal of Neuroscience Methods, 1994